|
|
|
|
| ORIGINAL ARTICLES |
  |
|
| Efficacy of peginterferon and ribavirin is associated
with the IL28B gene in Korean patients with chronic
hepatitis C |
| Seok Hoo Jeong1, Young Kul Jung1, Jae Won Yang2, Sang Jin Park2, Jong Woo Kim2, Oh Sang Kwon1, Yun Soo Kim1,
Duck Joo Choi1, and Ju Hyun Kim1 |
1Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University of Medicine and Science, Incheon;
2Laboratory of Infectious Disease, B&C Biopharm Co. Ltd., Suwon, Korea |
|
Corresponding Author:
Young Kul Jung ,Tel: +82-32-460-8201, Fax: +82-32-460-3408, Email: 93cool@hanmail.net |
 |
| ABSTRACT |
|
|
Background/Aims: Sustained virologic response (SVR) for the treatment of chronic hepatitis C (CHC) may differ with
ethnicity due to differences in genetic traits. This study evaluated the efficacy of peginterferon and ribavirin, and the
association between IL28B genotypes and the treatment efficacy in Korean CHC patients.
Methods: This was a retrospective cohort study using data from medical records. Eighty-five CHC patients were eligible
for assessment of the efficacy of antiviral therapy, and 47 patients were available for an IL28B genetic study, which was
performed using the Multiplex tetra-primer PCR method for rs12979860.
Results: Overall, the early virologic response rate was 87.1%: 84.9% in HCV genotype 1 and 90.6% in genotype 2. The
overall end-of-treatment virologic response rate was 81.2%: 75.5% in genotype 1 and 90.6% in genotype 2. The overall
SVR rate was 81.2%: 75.5% in genotype 1 and 90.6% in genotype 2. For rs12979860, the frequencies of polymorphisms
were 89% for the CC type, 11% for the CT type, and 0% for the TT type. Their overall SVR rate was 87% (39/47): 90.5% (38/42)
for the CC type and 20% (1/5) for the CT type. For genotype 1, SVR rates were 88% (21/24) for the CC type and 0% (0/4) for
the CT type. Multivariate analysis revealed that the IL28B-CC type was a good predictor for SVR.
Conclusions: The SVR of the combination therapy in Koreans was higher than that observed in Western countries. This
finding might be attributable to the high prevalence of IL28B-CC type among Koreans, which may be a good predictor of
SVR. |
| Keywords: Chronic hepatitis C; Peginterferon; Ribavirin; IL28B; Korea |
|
 |
| Don't forget to sign up for journal e-mail alerts so you can keep up to date with all the articles as they are published. |
|
 |
 |
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 Register for e-submission |
|
Register here to access the e-submission system of CMH for authors and reviewers.
|
| Manuscript Submission |
|
To submit a manuscript, please visit the CMH e-submission management system at http://submit.e-cmh.org, read the Instructions for Authors, and log into the CMH e-submission system. For assistance with manuscript submission, please contact: kasl@kams.or.kr.
|
| Free archive |
|
Anyone may access any past or current articles without logging in.
|
|
|
|
The Korean Association for the Study of the Liver
|
Room A1210, 53 Mapo-daero{MapoTrapalace , Dowha-dong}, Mapo-gu, Seoul, 121-784, Korea
TEL : +82-2-703-0051 FAX : +82-2-703-0071 E-mail : kasl@kams.or.kr |
Copyright © By The Korean Association for the Study of the Liver. All right reserved. 
|
|
|
| |